Logo
Secure Registration

International Conference on Diabetes, Endocrine, and Metabolic Disease Translational Research

ICDEMDTR

3rd Mar – 4th Mar 2027 Bangkok, Thailand

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Read the full Terms & Conditions

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 2 SDG 3 SDG 4 SDG 9
01 Advancements in Adipose Tissue Metabolism +
This session will explore the latest research on adipose tissue metabolism and its implications for obesity and diabetes. Presentations will focus on the cellular mechanisms and metabolic pathways involved in adipose tissue function.
SDG 3 SDG 4
02 Gene and Cell Therapies for Metabolic Disorders +
This track will discuss innovative gene and cell therapies aimed at treating inherited metabolic disorders. Researchers will present their findings on the efficacy and safety of these novel therapeutic approaches.
SDG 3 SDG 9
03 Immunometabolism and Its Role in Diabetes +
This session will delve into the intersection of immunology and metabolism, particularly how immune responses influence diabetes pathogenesis. Presenters will highlight recent discoveries linking inflammation to metabolic dysregulation.
SDG 3 SDG 9
04 Nutrition and Metabolic Responses +
This track will examine the impact of dietary patterns on metabolic health and disease outcomes. Experts will discuss the role of nutrition in managing diabetes and other metabolic disorders.
SDG 2 SDG 3
05 Mitochondrial Dysfunction in Metabolic Diseases +
This session will focus on the role of mitochondrial dysfunction in various metabolic diseases, including diabetes and obesity. Researchers will present findings on how mitochondrial health affects energy metabolism and disease progression.
SDG 3 SDG 9
06 Innovations in Cardiometabolic Disease Management +
This track will highlight cutting-edge strategies for managing cardiometabolic diseases, including diabetes and cardiovascular disorders. Presentations will cover both pharmacological and lifestyle interventions.
SDG 3 SDG 9
07 Genetic Insights into Metabolic Syndrome +
This session will explore the genetic factors contributing to metabolic syndrome and its components. Researchers will present data on gene-environment interactions and their implications for disease prevention.
SDG 3 SDG 9
08 Lysosomal Storage Disorders: Diagnosis and Treatment +
This track will focus on advancements in the diagnosis and treatment of lysosomal storage disorders. Experts will discuss the role of tandem mass spectrometry and emerging therapies in improving patient outcomes.
SDG 3 SDG 9
09 Obesity and Its Metabolic Consequences +
This session will examine the complex relationship between obesity and metabolic diseases, including diabetes and cardiovascular disorders. Researchers will present findings on the mechanisms linking obesity to metabolic dysregulation.
SDG 3 SDG 9
10 Endocrine Disorders and Metabolic Health +
This track will explore the interplay between endocrine disorders and metabolic health, focusing on conditions such as thyroid dysfunction and adrenal disorders. Presentations will highlight the impact of hormonal imbalances on metabolism.
SDG 3 SDG 4
11 Emerging Therapies in Diabetes and Metabolism +
This session will showcase novel therapeutic approaches for diabetes and metabolic disorders, including new pharmacological agents and lifestyle interventions. Researchers will discuss the potential of these therapies to transform patient care.
SDG 3 SDG 9